Multivalent Influenza Vaccines

Sanofi
Application Awaiting Examination App No 202317083196 Chemical

Patent information

IP India · live record
Application number
202317083196
Filing date
06 December 2023
Status
Application Awaiting Examination
Publication number
39/2024
Publication type
INA
Invention field
Chemical

Abstract

Provided are octavalent influenza vaccine compositions comprising eight mRNA, each mRNA comprising an open reading frame encoding a different influenza antigen. Also provided are lipid nanoparticles (LNPs) for delivering said mRNA.

Applicants

1
France
SANOFI 46 avenue de la Grande Armée 75017 Paris

Inventors

2
U.S.A.
ALEFANTIS, Timothyc/o Sanofi, Patent Department 50 Binney Street Cambridge, Massachusetts 02142
U.S.A.
CHIVUKULA, Sudhac/o Sanofi, Patent Department 50 Binney Street Cambridge, Massachusetts 02142

Documents

Sign in to open
Application documents
1 202317083196-TRANSLATIOIN OF PRIOIRTY DOCUMENTS ETC. [06-12-2023(online)].pdf 06 Dec 2023
2 202317083196-STATEMENT OF UNDERTAKING (FORM 3) [06-12-2023(online)].pdf 06 Dec 2023
3 202317083196-Sequence Listing in txt [06-12-2023(online)].txt 06 Dec 2023
4 202317083196-Sequence Listing in PDF [06-12-2023(online)].pdf 06 Dec 2023
5 202317083196-FORM 1 [06-12-2023(online)].pdf 06 Dec 2023
6 202317083196-DRAWINGS [06-12-2023(online)].pdf 06 Dec 2023
7 202317083196-DECLARATION OF INVENTORSHIP (FORM 5) [06-12-2023(online)].pdf 06 Dec 2023
8 202317083196-COMPLETE SPECIFICATION [06-12-2023(online)].pdf 06 Dec 2023
9 202317083196-FORM-26 [09-02-2024(online)].pdf 09 Feb 2024
10 202317083196-FORM 3 [28-05-2024(online)].pdf 28 May 2024
11 202317083196-Proof of Right [20-01-2025(online)].pdf 20 Jan 2025
12 202317083196-PA [27-05-2025(online)].pdf 27 May 2025
13 202317083196-ASSIGNMENT DOCUMENTS [27-05-2025(online)].pdf 27 May 2025
14 202317083196-8(i)-Substitution-Change Of Applicant - Form 6 [27-05-2025(online)].pdf 27 May 2025
15 202317083196-FORM 18 [10-06-2025(online)].pdf 10 Jun 2025